RI Medical Imaging Receives “Magna Cum Laude” for New Breast Cancer Procedure

GoLocalProv News Team

RI Medical Imaging Receives “Magna Cum Laude” for New Breast Cancer Procedure

RI Medical Imaging receives “Magna Cum Laude” for new breast cancer procedure
Rhode Island Medical Imaging (RIMI) has been awarded a “magna cum laude” designation for its work in the Freezing instead of Resection Of Small breast Tumors (FROST) clinical trial for breast cancer cryoablation at November’s Radiological Society of North America (RSNA).

The presentation “Freezing instead of excising: Cryoablation for breast cancer -- How it’s done” is based on the work of RIMI radiologist Dr. Robert C. Ward and his team.

“In the last year, I’ve treated almost 20 patients, some from out of state, and even from out of the country. Using this minimally invasive technique we can kill targeted tissue with extreme cold,” said Ward.

GET THE LATEST BREAKING NEWS HERE -- SIGN UP FOR GOLOCAL FREE DAILY EBLAST

Ward is the only doctor in New England that is currently doing this breast cancer procedure.

Cryoablation

Cryoablation has been used for liver, kidney and lung tumors as well as on abdominal wall endometriosis and fibroadenomas.

Cryoablation is better tolerated than heat-based modalities and requires only local anesthesia and no sedation.

This procedure has shown itself to be an alternative to resection in select breast cancer patients.

In clinical trials (2016) complete tumor ablation (tissue destruction) for invasive ductal carcinoma was more than 90 percent effective when tumors were less than 2 cm in size and 100 percent effective when tumors were less than 1 cm in size.


19 to Watch in 2019 - FULL LIST

Enjoy this post? Share it with others.